-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Organon & Co. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- Organon & Co. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $5 M, a 66.7% increase year-over-year.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2023 was -$485 M, a 2594% decline from 2022.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2022 was -$18 M, a 93.8% increase from 2021.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2021 was -$288 M, a 800% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)